foxo4-dri senolytic or senomorphic (Proxofim) 10mg*10 vials - Nexus peptides Targeting cellular senescence with senotherapeutics:

At 0.25mg per week, a 5mg vial theoretically contains 20 doses, but you can only use it for 4 weeks (28 days) after reconstitution

Cancer Chemother Pharmacol (2020) 85(1):617

These products were distributed to patients

Oral Capsule Bioavailability Oral administration represents the most familiar and convenient delivery method, but faces unique challenges with peptide compounds: Absorption Rate : 30-50% typical bioavailability [3] Key Challenges : Peptides must survive stomach acid (pH 1.5-3.5) Digestive enzymes (pepsin, trypsin) break down protein structures First-pass metabolism in liver reduces available compound Absorption occurs primarily in small intestine Despite these obstacles, BPC-157's inherent stability in gastric acid gives it an advantage over many other peptides